Apoprotein(a) [apoprotein(a)]
- Terms
-
apo Lp(a)
apolipoprotein (a)
apolipoprotein Lp(a)
apolipoprotein Lp(a+)
apolipoprotein(a)
apoprotein (a)
-
Antiangiogenic AK38 Protein
Apo Lp(a)
Apolipoprotein (a)
Apolipoprotein Lp(a)
Apolipoprotein Lp(a+)
Apolipoprotein(a)
Apoprotein (a)
A large and highly glycosylated protein constituent of LIPOPROTEIN (A). It has very little affinity for lipids but forms disulfide-linkage to APOLIPOPROTEIN B-100. Apoprotein(a) has SERINE PROTEINASE activity and can be of varying sizes from 400- to 800-kDa. It is homologous to PLASMINOGEN and is known to modulate THROMBOSIS and FIBRINOLYSIS.
- Annotation
- do not confuse with APOLIPOPROTEINS A, normal structural proteins of the alpha-lipoproteins (HIGH DENSITY LIPOPROTEINS)
- DUI
- D053241 MeSH Browser
- CUI
- M0001595
- Previous indexing
- Apolipoproteins (1977-1993); Apolipoproteins A (1982-2006); Apoproteins (1978-2004)
- History note
- 2007 (1986); use APOLIPOPROTEINS A 1988-2006
- Public note
- 2007; see APOLIPOPROTEINS A 1988-2006; APOLIPOPROTEIN LP(A+) was indexed under APOLIPOPROTEINS & LIPOPROTEIN(A) 1986-2006
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood 2
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DF
- deficiency
- DE
- drug effects 1
- EC
- economics
- GE
- genetics 2
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine